A 60-Year Old Man With Untreated Stage IV EGFR-Mutated Non-Small Cell Lung Cancer
EP. 1: A 60-Year-Old Male With Stage IV EGFR+ NSCLC
Watch
EP. 2: Waiting for Results of Molecular Testing in NSCLC
EP. 3: Treatment Choices for EGFR+ NSCLC
EP. 4: Treatment After Progression on Osimertinib for EGFR+ NSCLC
EP. 5: Future Directions in Treating NSCLC
